Spriza Inc (SPRZ) 0.2500 $SPRZ Spriza Responds to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Spriza Inc (SPRZ) 0.2500 $SPRZ

Spriza Responds to Temporary Trading Halt
Filing Services Canada XHTML - Wed Mar 25, 8:02AM CDT


Advent Financial Initiates Coverage of Spriza, Inc. (OTCQB: SPRZ)
Marketwired - Mon Mar 02, 5:00AM CST
Advent Financial is pleased to announce that it has initiated research coverage on Spriza, Inc. (OTCQB: SPRZ). Based on our valuation analysis we estimate the target price to be as high as $2.71 per share.

Spriza Closes Financing
Marketwired - Fri Feb 13, 8:16AM CST
Spriza, Inc. ("Spriza" or the "Company" (OTCQB: SPRZ) (www.spriza.com), the world's leading social network for group prizes and incentives, is pleased to announce that on February 9, 2015 the Company closed a non-brokered private placement of 1,600,000 common shares, for total proceeds of US$800,000. Warrants have also been exercised for 397,800 common shares for additional proceeds of US$198,900 bringing the total proceeds to US$998,900. The common shares will be issued with a restrictive legend to satisfy all hold periods required by all applicable securities rules and regulations.

Spriza Provides Corporate Update
Marketwired - Thu Feb 12, 8:16AM CST
Spriza, Inc. ("Spriza" (OTCQB: SPRZ), the world's leading social network for group prizes and incentives today announced the release of its SPRIZA(TM) Do-it-Yourself ("DIY" contest building and toolbox platform for small and medium sized businesses.

Spriza Attracts Millions of Users - Releases Android Mobile App
Marketwired - Fri Feb 06, 5:36PM CST
Spriza, Inc. ("Spriza" (OTCQB: SPRZ), (the "Company" (www.spriza.com), the world's leading social network for group prizes and incentives, is pleased to announce the Company has begun beta testing its native app for the Android platform.

Spriza Contest Exceeds Expectations
Marketwired - Thu Feb 05, 3:31PM CST
Spriza, Inc. ("Spriza" (the "Company" (OTCQB: SPRZ) (www.spriza.com), the world's leading social network for group prizes and incentives, is pleased to announce results of a contest it initiated in January of 2015. Spriza administered a 30 day contest for a client that operates one of the world's top online game applications. Traffic generated during the first 24 hours of the SPRIZA(TM) enabled contest was unprecendented and exceeded the client's overall objectives for the campaign.

Spriza Announces March 2014 Private Placement
Marketwired - Fri Jan 30, 3:41PM CST
Spriza, Inc. ("Spriza" (OTCQB: SPRZ), the world's leading social network for group prizes and incentives, today announced that, on March 10, 2014, Spriza issued a total of 1,540,800 units of Spriza, at a price of US $0.25 per unit, for total proceeds of $385,200. Each unit is comprised of one common share of Spriza and one common share purchase warrant of Spriza. Each share purchase warrant is exercisable into one additional common share of Spriza, at a price of US $0.50 per common share, until March 10, 2015.

Spriza Announces November 2013 Private Placement
Marketwired - Fri Jan 30, 3:29PM CST
Spriza, Inc. ("Spriza" (OTCQB: SPRZ), the world's leading social network for group prizes and incentives, today announced that, on November 1, 2013, Spriza completed a non-brokered private placement of 1,500,201 units of Spriza, at a price of US $0.15 per unit, for total proceeds of $225,030. Each unit is comprised of one common share of Spriza and one common share purchase warrant of Spriza. Each share purchase warrant is exercisable into one additional common share of Spriza, at a price of US $0.30 per common share, until November 1, 2016.

Spriza Announces June 2014 Share Transfer
Marketwired - Fri Jan 30, 3:25PM CST
Spriza, Inc. ("Spriza" (OTCQB: SPRZ), the world's leading social network for group prizes and incentives, today announced that, on June 14, 2014, Adrian Ansell, a significant shareholder of Spriza, gifted to Robert Danard, a Director and the Chief Executive Officer of Spriza, a total of 15,500,000 common shares of Spriza.

Spriza Approves Change of Auditor
Marketwired - Thu Jan 29, 2:13PM CST
Spriza, Inc. (OTCQB: SPRZ) has approved a change of auditors.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 5

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 9

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 8

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bryan Leon Joins Storm Properties to Elevate Acquisitions Team

Updated Category News Views 381

Storm Properties Welcomes Bryan Leon as New Hire Storm Properties Inc., recognized as a significant player in the development, ownership, and management of a variety of properties, is delighted to announce the addition of Bryan Leon to their team as Land Acquisitions Manager. This appointment comes as part of the company's ongoing strategy to strengthen its position in...

Continue Reading
Revolutionizing Trade Setups with Innovative Scanner Technology

Updated Category News Views 280

Revolutionizing Trade Setups with Innovative Scanner Technology Stock Market Guides is thrilled to introduce significant advancements to its cutting-edge stock scanner technology. The latest update empowers users by showcasing the historical track record of various trade setups it identifies, offering unparalleled insight to traders looking to enhance their market...

Continue Reading
EQT Life Sciences Champions $39 Million Investment in Aerska

Updated Category News Views 101

EQT Life Sciences Champions $39 Million Investment in Aerska Advancing RNA Therapeutics EQT Life Sciences has recently announced a significant milestone: leading a $39 million Series A financing round in Aerska. This funding will be instrumental in pushing forward Aerska’s innovative brain shuttle technology. Designed to optimize the delivery of RNA interference...

Continue Reading
NVIDIA's Anticipated Earnings Report: Key Insights for Investors

Updated Category News Views 160

Understanding NVIDIA's Upcoming Earnings Announcement NVIDIA (NASDAQ: NVDA) is set to release its much-anticipated quarterly earnings report soon. Investors are keen to understand how the company is performing and what guidance it will provide for future quarters. Analysts predict that NVIDIA will announce an earnings per share (EPS) of $0.98, which indicates the level of...

Continue Reading
Innovative Partnership Forged for Enhanced Vehicle Safety

Updated Category News Views 185

Innovative Partnership Forged for Enhanced Vehicle Safety NOVOSENSE Microelectronics, a key player in the semiconductor industry known for its high-performance analog and mixed-signal chips, is joining hands with Continental Automotive Technologies to enhance vehicle safety systems. This collaboration aims to push the envelope in developing automotive-grade sensors that...

Continue Reading